Intensive Course in Genetic Cancer Risk Assessment
The Intensive Course 2025 application is now OPEN
- The IC 2025 session starts on October 25, 2024, and ends March 14, 2025.
- The IC 2025 application will be open from April 1, 2024 to August 1, 2024.
For course or application inquiries, please complete an inquiry form.
The Intensive Course in Genomic Cancer Risk Assessment is a continuing medical education course for Physicians, Physician Assistants, Genetic Counselors, Master's or PhD in Genetics or Advanced Practice Nurses, and Geneticists.
The course runs from October through February each year. Track 1 of the course combines distance learning with a four-day series of in-person workshops, and Track 2 offers online distance-learning only. The only difference between the two tracks is that Track 1 offers four days of in-person workshops.
Learning Outcomes
At the conclusion of the Intensive Course in Genomic Cancer Risk Assessment, participants will be able to:
- Integrate cancer genetics and oncology knowledge into clinical practice
- Apply skills commensurate with practitioner-level proficiency into the cancer risk assessment and case management process
- Recommend risk-appropriate options for cancer surveillance and prevention as part of the cancer risk assessment, including imaging, chemopreventive and surgical interventions
- Incorporate understanding of medical, ethical, legal, and psychosocial ramifications of cancer risk counseling and testing into clinical practice and research collaboration
- Examine the value of hereditary cancer registries, cancer epidemiology and cancer prevention studies for patients and clinicians
- Realize greater professional self-efficacy related to genetic cancer risk assessment skills
- Incorporate Web-based resources into ongoing practice-based education, professional development, and research support
- Discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics)
Alumni of the course have the option to join our Clinical Cancer Genomics Community of Practice, a network currently numbering more than 1,000 clinicians, and to participate in our Clinical Cancer Genomics Community Research Network.